Sort
64,565 grants matching “drug discovery”
Transforming Life Sciences: Artificial Life
$658,230Steven A Benner · Foundation For Applied Molecular Evolutn · R01 · FY2019 · GM
Transforming Life Sciences: Artificial Life
$658,230Steven A Benner · Foundation For Applied Molecular Evolutn · R01 · FY2017 · GM
Transforming Life Sciences: Artificial Life
$658,230Steven A Benner · Foundation For Applied Molecular Evolutn · R01 · FY2020 · GM
In Vitro Core
$658,181Michael A Hoffman · University Of Wisconsin-Madison · U19 · FY2017 · AI
Effects of ions on mRNA elements, ribosomes and antibiotic-RNA interactions
$658,165Karissa Y Sanbonmatsu · Triad National Security, Llc · R35 · FY2025 · GM
Microfibril deficiency in glaucoma pathogenesis
$658,163Rachel W Kuchtey · Vanderbilt University Medical Center · R01 · FY2018 · EY
Microfibril deficiency in glaucoma pathogenesis
$658,163Rachel W Kuchtey · Vanderbilt University Medical Center · R01 · FY2017 · EY
Agincourt II Nanovolume Protein Crystallization Robot
$658,155Syrrx, Inc. · R44 · FY2004 · RR
In Silico Screening of Medications for Slowing Alzheimer's Disease Progression.
$658,103Richard E Kennedy · University Of Alabama At Birmingham · R01 · FY2017 · AG
Orally-Bioavailable Peroxynitrite Decomposition Catalyst Targeting Post-Surgical Pain
$658,085Scott L Dax · Cersci Therapeutics, Inc. · R44 · FY2017 · DA
Large-Scale Production of High Purity Human Cortical Glutamatergic Neurons
$658,043Zhong-Wei Du · Brainxell, Inc. · R44 · FY2018 · MH
Discovery and Analysis of Synthetic TLR Agonists and Antagonists
$658,004Bruce A Beutler · Scripps Research Institute, The · U24 · FY2010 · AI
Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic Microorganisms
$658,000Gaetano T Montelione · Rensselaer Polytechnic Institute · R35 · FY2024 · GM
Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic Microorganisms
$658,000Gaetano T Montelione · Rensselaer Polytechnic Institute · R35 · FY2022 · GM
Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic Microorganisms
$658,000Gaetano T Montelione · Rensselaer Polytechnic Institute · R35 · FY2025 · GM
Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic Microorganisms
$658,000Gaetano T Montelione · Rensselaer Polytechnic Institute · R35 · FY2021 · GM
Hybrid Methods for Dynamic Structure Analysis of Proteins from Pathogenic Microorganisms
$658,000Gaetano T Montelione · Rensselaer Polytechnic Institute · R35 · FY2023 · GM
Preclinical validation of ABHD5 as a target for treatment of obesity.
$657,958James G Granneman · Wayne State University · R01 · FY2017 · DK
Imputation-based approach to identify low frequency variants in prostate cancer
$657,827Fredrick Ray Schumacher · University Of Southern California · U01 · FY2014 · CA
Phenotypic marker-guided development of selective antimetastasis therapeutic leads
$657,810Sui Huang · Northwestern University At Chicago · R01 · FY2022 · CA
Highly tumor-selective pan RAS inactivators for targeting oncogenic RAS-driven cancers
$657,776Shihui Liu · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Microbial Observatories: Collaborative Research: Salt Plains Microbial Observatory
$657,727William J Henley · Oklahoma State University · · FY2002 · BIO
EBV NUCLEAR PROTEINS IN B CELL GROWTH TRANSFORMATION
$657,708Brigham And Women'S Hospital · R01 · FY2003 · CA
Discovery of SARS-CoV-2 antivirals using a replicon assay
$657,615Stefan G Sarafianos · Emory University · R01 · FY2022 · AI
Proline homeostasis: a novel mediator of drug tolerance in Plasmodium falciparum
$657,600Ralph Mazitschek · Harvard School Of Public Health · R01 · FY2020 · AI